Cas no 150017-89-3 (1,9-Dibromononane-d18)
1,9-Dibromononane-d18 Chemical and Physical Properties
Names and Identifiers
-
- Nonane-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-d18,1,9-dibromo- (9CI)
- 1,9-DIBROMONONANE-D18
- 150017-89-3
- D98488
- HY-32874S
- CS-0568214
- AKOS015914311
- 1,9-Dibromononane-d18
-
- Inchi: 1S/C9H18Br2/c10-8-6-4-2-1-3-5-7-9-11/h1-9H2/i1D2,2D2,3D2,4D2,5D2,6D2,7D2,8D2,9D2
- InChI Key: WGAXVZXBFBHLMC-ZOJCSGEHSA-N
- SMILES: BrC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])Br
Computed Properties
- Exact Mass: 304.088
- Monoisotopic Mass: 302.091
- Isotope Atom Count: 18
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 0
- Heavy Atom Count: 11
- Rotatable Bond Count: 8
- Complexity: 56.6
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.3
- Topological Polar Surface Area: 0A^2
1,9-Dibromononane-d18 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D211081-1mg |
1,9-Dibromononane-d18 |
150017-89-3 | 1mg |
$ 64.00 | 2023-09-08 | ||
| TRC | D211081-2mg |
1,9-Dibromononane-d18 |
150017-89-3 | 2mg |
$81.00 | 2023-05-18 | ||
| TRC | D211081-10mg |
1,9-Dibromononane-d18 |
150017-89-3 | 10mg |
$ 115.00 | 2023-09-08 |
1,9-Dibromononane-d18 Related Literature
-
Ruili Liu,Mengping Gao,Jing Zhang,Zhilian Li,Jinyang Chen,Ping Liu,Dongqing Wu RSC Adv., 2015,5, 24205-24209
-
Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
-
H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
-
Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
Additional information on 1,9-Dibromononane-d18
Professional Introduction to 1,9-Dibromononane-d18 (CAS No. 150017-89-3)
The compound 1,9-Dibromononane-d18, with the CAS number 150017-89-3, is a specialized isotope-labeled chemical widely utilized in the field of pharmaceutical research and organic synthesis. This compound, featuring a nonane backbone substituted with two bromine atoms at the 1st and 9th carbon positions, and incorporating deuterium atoms for isotopic labeling, serves as a crucial intermediate in the development of advanced chemical methodologies.
In recent years, the demand for high-purity labeled compounds has surged due to their significance in analytical chemistry and drug discovery processes. The use of deuterated analogs, such as 1,9-Dibromononane-d18, allows researchers to study metabolic pathways and reaction mechanisms with greater precision. The introduction of deuterium atoms into molecular structures enhances the stability of intermediates and products, facilitating more accurate mass spectrometry analyses and NMR spectroscopy studies.
The brominated version of this compound is particularly valuable in cross-coupling reactions, a cornerstone of modern synthetic organic chemistry. These reactions are pivotal in constructing complex molecular frameworks, which are often required in the synthesis of novel pharmaceutical agents. The presence of bromine atoms at specific positions on the nonane chain provides reactive sites that can be selectively modified via palladium-catalyzed reactions, such as Suzuki-Miyaura or Heck couplings. Such transformations are indispensable in the preparation of biaryl compounds and heterocyclic structures prevalent in medicinal chemistry.
Recent advancements in drug development have highlighted the importance of isotopically labeled compounds in pharmacokinetic studies. The incorporation of deuterium into drug molecules can lead to improved metabolic stability and reduced clearance rates, potentially extending the therapeutic window of a drug. For instance, deuterated analogs of existing medications have shown promise in maintaining efficacy while minimizing side effects. The compound 1,9-Dibromononane-d18 can serve as a key building block in synthesizing these advanced drug candidates.
The synthesis of 1,9-Dibromononane-d18 involves careful consideration of reaction conditions to ensure high yield and purity. Modern synthetic techniques often employ transition metal catalysts and controlled stoichiometry to achieve optimal results. The bromination process typically requires precise temperature control and anhydrous conditions to prevent unwanted side reactions. Additionally, the isotopic labeling step demands specialized equipment to incorporate deuterium atoms efficiently without compromising structural integrity.
In industrial applications, the compound is often used as a precursor for more complex derivatives. Its versatility allows for modifications at multiple positions, enabling chemists to tailor molecular properties for specific applications. For example, further functionalization can yield compounds suitable for polymer synthesis or material science research. The ability to precisely control molecular structure makes 1,9-Dibromononane-d18 a valuable asset in both academic and industrial laboratories.
The role of computational chemistry in optimizing synthetic routes for such compounds cannot be overstated. Molecular modeling software aids researchers in predicting reaction outcomes and identifying potential pitfalls before conducting experiments. This approach not only saves time but also reduces waste by minimizing trial-and-error experimentation. As computational power increases, the design and synthesis of complex labeled compounds like 1,9-Dibromononane-d18 are becoming increasingly efficient.
Ethical considerations also play a significant role in the handling and use of specialized chemicals like 1,9-Dibromononane-d18. Ensuring proper storage conditions and disposal protocols is essential to maintain safety standards in laboratory environments. Regulatory agencies often provide guidelines to minimize risks associated with working with isotopically labeled substances, emphasizing the importance of trained personnel and appropriate safety measures.
The future prospects for this compound remain promising as new methodologies emerge in synthetic chemistry and drug discovery. Innovations such as flow chemistry and green chemistry principles are expected to further enhance the efficiency and sustainability of processes involving 1,9-Dibromononane-d18. As research continues to evolve, this compound will likely find even broader applications across various scientific disciplines.
150017-89-3 (1,9-Dibromononane-d18) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)